Skip to content
Peptilyze
CompoundsShopsCompareGuidesMethod
Growth hormone axis

CJC-1295 (no DAC) studies

18 journal papers mention CJC-1295 (no DAC) in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether CJC-1295 (no DAC) is safe, effective or approved for any use.

Compare CJC-1295 (no DAC) prices, from €19.99 →

Papers
18
14 articles, 4 reviews
Earliest paper
2005
Most papers in 2026 (7)
Open access
50%
free to read somewhere
Reviews
22%
of all papers listed

What kind of studies

Of 35 papers in PubMed that mention CJC-1295 (no DAC) in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials1
  • Other clinical trials1
  • Meta-analyses and systematic reviews0
  • Other reviews11
  • Case reports0
  • Animal studies only5
  • Studies in humans22

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Registered clinical studies

Studies on ClinicalTrials.gov that mention CJC-1295 (no DAC) in their intervention details. A registration says a study is planned or running, not what it found.

Registered
1
Completed
0
Ongoing or planned
0
Phase 1
0
Phase 2
1
Phase 3
0
  1. A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

    NCT00267527TerminatedPhase 2started 2005-12

The five most recently updated studies. See all 1 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.

Papers per year

2005 to 2026, peak 7 papers in a year. The latest year may still be incomplete.

2005: 1 papers2006: 3 papers2007: 0 papers2008: 0 papers2009: 2 papers2010: 0 papers2011: 0 papers2012: 0 papers2013: 0 papers2014: 0 papers2015: 0 papers2016: 1 papers2017: 0 papers2018: 0 papers2019: 1 papers2020: 0 papers2021: 1 papers2022: 0 papers2023: 0 papers2024: 1 papers2025: 1 papers2026: 7 papers20052026

Where it is published

  1. The American Journal of Sports Medicine2 papers
  2. The Journal of Clinical Endocrinology & Metabolism2 papers
  3. Annales de Toxicologie Analytique2 papers
  4. Talanta1 papers
  5. Proceedings of the National Academy of Sciences1 papers

The papers

ShowAllOpen accessReviews

Most citedName in the title

  1. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

    Lucila Sackmann‐Sala, Juan Ding, Lawrence A. Frohman et al. · Growth Hormone & IGF Research · 2009

    Study in humansOpen access28 citationsRead the open copy →

LatestName in title or abstract

  1. The peptide boom: a critical appraisal of evidence, patient safety risks, and regulatory failure in the experimental wellness peptide market

    Giorgi Pkhakadze · Georgian Medical Journal · 2026

    Open access · CC BYRead the open copy →

  2. Peptide Supplements and Their Therapeutic Applications in Sports Medicine

    Kushagra Tewari, Timothy P. Liu, Christina Im et al. · The American Journal of Sports Medicine · 2026

    Open access · CC BY1 citationsRead the open copy →

  3. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

    Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz et al. · Frontiers in Endocrinology · 2026

    ReviewOpen access · CC BY1 citationsRead the open copy →

  4. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging

    Volodymyr Mavrych, Inna Shypilova, Olena Bolgova · Frontiers in Aging · 2026

    ReviewOpen access · CC BY5 citationsRead the open copy →

  5. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    Omar F. Rahman, Steven J. Lee, William A. Seeds · JAAOS Global Research and Reviews · 2026

    ReviewOpen access · CC BY-NC-ND5 citationsRead the open copy →

  6. (197) Peptides in Practice: Evaluating Efficacy and Safety in Men’s Health

    R Arora, Arjun K. Venkatesh, Gene Austin Krishingner et al. · The Journal of Sexual Medicine · 2025

    Open accessRead the open copy →

  7. Novel wellbeing and repair peptide use in the UK: Netnographic findings

    Luke A. Turnock, Evelyn Hearne · Performance Enhancement & Health · 2024

    Open access · CC BY11 citationsRead the open copy →

  8. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

    Lucila Sackmann‐Sala, Juan Ding, Lawrence A. Frohman et al. · Growth Hormone & IGF Research · 2009

    Study in humansOpen access28 citationsRead the open copy →

  9. Neuronal M 3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth

    Dinesh Gautam, Jongrye Jeon, Matthew F. Starost et al. · Proceedings of the National Academy of Sciences · 2009

    Animal studyOpen access39 citationsRead the open copy →

Each list shows up to 40 papers.See all 18 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.